sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma (Q40618753)

22 September 2017

title

sFlt-1 gene therapy of follicular thyroid carcinoma (English)

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

22 September 2017

sFlt-1 Gene Therapy of Follicular Thyroid Carcinoma (English)

1 reference

30 March 2024

0 references

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Caisheng Ye

1 reference

22 September 2017

Chong Feng

1 reference

22 September 2017

Shenming Wang

1 reference

22 September 2017

Nancy Huang

1 reference

22 September 2017

Xiaoning Liu

1 reference

22 September 2017

Yongjie Lin

1 reference

22 September 2017

Mengfeng Li

1 reference

22 September 2017

Kent Z. Q. Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605010

reference URL

30 March 2024

language of work or name

English

0 references

publication date

6 November 2003

1 reference

full work available at URL

22 September 2017

published in

Endocrinology

1 reference

22 September 2017

volume

145

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

817-822

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Clinical translation of angiogenesis inhibitors

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Vascular endothelial growth factor is a secreted angiogenic mitogen

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Growth factor signaling by receptor tyrosine kinases

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

VEGF receptor signaling and endothelial function.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Human endothelial cell growth factors derived from thyroid anaplastic cell carcinoma

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Angiogenesis in follicular tumors of the thyroid

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Assays for angiogenesis: A review

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Suramin is a Potent Inhibitor of Vascular Endothelial Growth Factor. A Contribution to the Molecular Basis of its Antiangiogenic Action

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Adenoviral vector-mediated gene transfer for human gene therapy

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Progress toward vector design for hematopoietic stem cell gene therapy

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

New agents for the treatment of renal cell carcinoma

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

VEGF-Trap: a VEGF blocker with potent antitumor effects

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Combined effects of angiostatin and ionizing radiation in antitumour therapy

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

30 March 2024

1 reference

https://api.crossref.org/works/10.1210/EN.2003-1106

30 March 2024

Identifiers

DOI

10.1210/EN.2003-1106

1 reference

22 September 2017

1 reference